1. The use of a composition comprising galactooligosaccharide, fructooligosaccharide and uronic acid oligosaccharide in the preparation of a composition for preventing topical use of corticosteroids and / or preventing the administration of a calcineurin inhibitor. ! 2. The use according to claim 1, where the uronic acid oligosaccharide obtained from pectin. ! 3. The use according to claim 1, where the composition is administered orally to a nursing infant aged 0 to 12 months. ! 4. The use according to any one of claims 1 to 3, where the composition contains a lipid, protein and carbohydrate, where the lipid provides from 5 to 50% of the total calorie content of the composition, the protein provides from 5 to 50% of the total calorie content of the composition and carbohydrate from 15 to 90% total calorie composition. ! 5. The use according to any one of claims 1 to 3 to prevent the use of a drug selected from the group consisting of alklomethasone dipropionate, amcinonide, beclomethasone dipropionate, betamethasone benzoate, betamethasone dipropionate, betamethasone valerate, budesonide, clobetasol propionate, clobetasone butonate, , diphlorazone diacetate, diflucortolone valerate, flumethasone pivalate, fluchlorolone acetonide, fluocinolone acetonide, fluocinonide, fluocortinbutyl, fluocortolone, flupredniden acetate, flu andrenolona, fluticasone propionate, galtsinonida, halobetasol propionate, hydrocortisone, hydrocortisone acetate, hydrocortisone butyrate, hydrocortisone valerate, methylprednisolone acetate, mometasone furoate, triamcinolone acetonide, pimecrolimus, tacrolimus and mixtures thereof.1. Применение композиции, содержащей галактоолигосахарид, фруктоолигосахарид и олигосахарид уроновой кислоты, при получении композиции для предотвращения местного применения кортикостероидов и/или предотвращения введения ингибитора кальцинейрина. ! 2. Применение по п.1, где олигосахарид уроновой кислоты получен из пектина. ! 3. Применение по п.1, где композиция ввод
